Melanoma genetics: clinical translation of the germline-somatic continuum [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description While new targeted and immune therapies can improve prognosis from metastatic melanoma, long-term survival for most patients remains elusive due to drug resistance or failure of the immune system to kill the tumour. There thus remains a significant need to improve early detection, monitoring of relapse, and treatment strategies, to increase survival and provide cures. My research vision addresses these three pillars of cancer research using innovative and cutting edge genetic approaches.

Funding Amount $2,231,372

Funding Scheme Investigator Grants

Chief Investigator Prof Nicholas Hayward

Notes Leadership 3